Cargando…
Thrombospondin-1 is a prognostic biomarker and is correlated with tumor immune microenvironment in glioblastoma
Glioblastoma (GBM) is the most common malignant brain tumor and the most aggressive type of glioma, characterized by strong invasive potential and rapid recurrence despite severe treatment methods, such as maximal tumor resection followed by chemotherapy and radiotherapy. Thrombospondin-1 (THBS1) wa...
Autores principales: | Qi, Chunxiao, Lei, Lei, Hu, Jinqu, Wang, Gang, Liu, Jiyuan, Ou, Shaowu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681197/ https://www.ncbi.nlm.nih.gov/pubmed/33240428 http://dx.doi.org/10.3892/ol.2020.12283 |
Ejemplares similares
-
T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme
por: Qi, Chunxiao, et al.
Publicado: (2021) -
Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations
por: Qi, Chunxiao, et al.
Publicado: (2022) -
Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis
por: Qi, Chunxiao, et al.
Publicado: (2020) -
Systematic identification of lncRNA-based prognostic biomarkers for glioblastoma
por: Li, Mingdong, et al.
Publicado: (2019) -
Thrombospondins and remodeling of the tumor microenvironment
por: Stenina-Adognravi, Olga, et al.
Publicado: (2018)